STF-118804 is primarily researched for its potential in cancer therapy. It has shown promise in targeting cancer cells by inhibiting specific pathways that are crucial for their survival and proliferation. This compound is particularly studied for its ability to overcome drug resistance in certain types of cancer, making it a potential candidate for treating cancers that do not respond well to conventional therapies. Researchers are exploring its efficacy in preclinical models to understand its mechanism of action and to evaluate its safety and effectiveness for future clinical applications.